MindMed has today announced the launch of Project Angie, which will develop psychedelics (including LSD) for the treatment of pain conditions. At present, the New York-based company has unveiled 2 pain indications that will be explored: a severe pain indication, for which LSD will be studied; a chronic pain indication MindMed plans to submit an IND briefing package for LSD in the treatment of the…


Previous articleSmall Pharma Inc. to Commence Trading on the TSX Venture Exchange on May 6, 2021
Next articleRed Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data